ERBB2 and breast carcinoma: The human epidermal growth factor receptor 2 (HER2) is a transmembrane glycoprotein [47,48], shown to be overexpressed in 15–20% of breast cancers and conferring worse prognosis [49,50,51,52,53,54,55,56].